Did the FDA Move Too Slowly in Fully Approving the Pfizer-BioNTech Vaccine?

The Food and Drug Administration recently gave full approval to the COVID-19 vaccine developed by Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX). Some feel that the FDA might have acted too hastily. However, there are also some scientists who have an entirely different view. In this Motley Fool Live video recorded on Aug. 25, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not the FDA moved too slowly in approving the vaccine.

Continue reading

Source Fool.com